UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 326

Sortiert nach

Epidemiology of infections caused by polymyxin-resistant pathogens

International journal of antimicrobial agents, 2016-12, Vol.48 (6), p.614-621

Giamarellou, Helen

2016

Link zum Volltext

Verfügbarkeit prüfen

Carbapenem-Sparing Strategies for ESBL Producers: When and How

Antibiotics (Basel), 2020-02, Vol.9 (2), p.61

2020

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2388-2390

2013

Link zum Volltext

Verfügbarkeit prüfen

Metallo-β-lactamases: a last frontier for β-lactams?

The Lancet infectious diseases, 2011-05, Vol.11 (5), p.381-393

2011

Link zum Volltext

Verfügbarkeit prüfen

Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review

International journal of antimicrobial agents, 2013-06, Vol.41 (6), p.499-508

2013

Link zum Volltext

Verfügbarkeit prüfen

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients

Antibiotics (Basel), 2022-07, Vol.11 (8), p.1009

2022

Link zum Volltext

Verfügbarkeit prüfen

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

BMC infectious diseases, 2019-02, Vol.19 (1), p.167-167, Article 167

2019

Link zum Volltext

Verfügbarkeit prüfen

Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4241-4249

2012

Link zum Volltext

Verfügbarkeit prüfen

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

European journal of clinical microbiology & infectious diseases, 2021, Vol.40 (1), p.219-224

2021

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-resistant Gram-negative bacteria: how to treat and for how long

International journal of antimicrobial agents, 2010-12, Vol.36, p.S50-S54

Giamarellou, Helen

2010

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

Expert opinion on pharmacotherapy, 2014-07, Vol.15 (10), p.1351-1370

2014

Link zum Volltext

Verfügbarkeit prüfen

Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment

The Journal of infection, 2019-10, Vol.79 (4), p.312-321

2019

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2395-2397

2011

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Stewardship in the Hospital Setting: A Narrative Review

Antibiotics (Basel), 2023-10, Vol.12 (10), p.1557

2023

Link zum Volltext

Verfügbarkeit prüfen

The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design

Hellenic journal of cardiology, 2020-01, Vol.61 (1), p.42-45

2020

Link zum Volltext

Verfügbarkeit prüfen

Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.668-671

2013

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

BMC infectious diseases, 2019-03, Vol.19 (1), p.230-230, Article 230

2019

Link zum Volltext

Verfügbarkeit prüfen

Colistin susceptibility testing by Etest and disk diffusion methods

International journal of antimicrobial agents, 2008-05, Vol.31 (5), p.434-439

2008

Link zum Volltext

Verfügbarkeit prüfen

Evolution of epidemiological characteristics of infective endocarditis in Greece

International journal of infectious diseases, 2021-05, Vol.106, p.213-220

2021

Link zum Volltext

Verfügbarkeit prüfen

Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolates?

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.2133-2135

2009

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals

Antimicrobial Agents and Chemotherapy, 2006-09, Vol.50 (9), p.3166-3169

2006

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates

Journal of global antimicrobial resistance., 2020-03, Vol.20, p.98-104

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Tigecycline Alone and in Combination with Gentamicin in the Treatment of Experimental Endocarditis Due to Linezolid-Resistant Enterococcus faecium

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.3392-3394

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 326

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(299)
Mit Volltextzugriff
(281)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(259)
Life Sciences & Biomedicine
(257)
Humans
(207)
Infectious Diseases
(180)
Microbiology
(145)
Pharmacology & Pharmacy
(145)
Biological And Medical Sciences
(141)
Medical Sciences
(137)
Male
(110)
Pharmacology. Drug Treatments
(103)
Female
(99)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(98)
Middle Aged
(79)
Anti-Bacterial Agents - Therapeutic Use
(77)
Microbial Sensitivity Tests
(68)
Anti-Bacterial Agents - Pharmacology
(67)
Aged
(65)
Adult
(61)
Antibacterial Agents
(48)
Antibiotics
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Epidemiology of infections caused by polymyxin-resistant pathogens

Carbapenem-Sparing Strategies for ESBL Producers: When and How

Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae

Metallo-β-lactamases: a last frontier for β-lactams?

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

Multidrug-resistant Gram-negative bacteria: how to treat and for how long

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment

In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development

Antimicrobial Stewardship in the Hospital Setting: A Narrative Review

The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design

Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

Correction to: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

Colistin susceptibility testing by Etest and disk diffusion methods

Evolution of epidemiological characteristics of infective endocarditis in Greece

Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolates?

In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals

Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates

Efficacy of Tigecycline Alone and in Combination with Gentamicin in the Treatment of Experimental Endocarditis Due to Linezolid-Resistant Enterococcus faecium

Suchergebnisse filtern